Peptide-based pan-CoV fusion inhibitors maintain high potency against SARS-CoV-2 Omicron variant

作者：Shuai Xia, Jasper Fuk‐Woo Chan, Lijue Wang, Fanke Jiao, Kenn Ka‐Heng Chik, Hin Chu, Qiaoshuai Lan, Wei Xu, Qian Wang, Chao Wang, Kwok‐Yung Yuen, Lu Lu, Shibo Jiang · 发表于：Cell Research · 年份：2022 · DOI：10.1038/s41422-022-00617-x · 被引用次数：40 · 研究领域：SARS-CoV-2 and COVID-19 Research、SARS-CoV-2 detection and testing、COVID-19 Clinical Research Studies